New asthma treatments to be listed on Pharmaceutical Benefits Scheme

Daily Telegraph

18 December 2016 - Life-saving new treatments for asthma that currently cost patients $700 a year will be listed on the Pharmaceutical Benefits Scheme from next year.

More than one in three asthma sufferers have uncontrolled symptoms despite using puffers.

Tomorrow Treasurer Scott Morrison will confirm in the midyear fiscal outlook that Australia will spend another $130 million on the taxpayer-funded drug subsidy scheme to fight asthma with new drugs.

Read Daily Telegraph article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Listing , Australia